Advances in designing of polymeric micelles for biomedical application in brain related diseases

J Kaur, M Gulati, B Kapoor, NK Jha, PK Gupta… - Chemico-Biological …, 2022 - Elsevier
In recent years, unique physicochemical properties of amphiphilic block copolymers have
been utilized to design the polymeric micelles for brain-specific delivery of drugs, proteins …

Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders

D Kempuraj, KD Dourvetakis, J Cohen… - Frontiers in Cellular …, 2024 - frontiersin.org
Neurovascular unit (NVU) inflammation via activation of glial cells and neuronal damage
plays a critical role in neurodegenerative diseases. Though the exact mechanism of disease …

[HTML][HTML] Alleviation of cognitive impairment-like behaviors, neuroinflammation, colitis, and gut dysbiosis in 5xFAD transgenic and aged mice by Lactobacillus mucosae …

X Ma, JK Kim, YJ Shin, YH Son, DY Lee, HS Park… - Nutrients, 2023 - mdpi.com
Neuropsychiatric disorders including Alzheimer's disease (AD) may cause gut inflammation
and dysbiosis. Gut inflammation-suppressing probiotics alleviate neuropsychiatric disorders …

Protective effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide against cognitive decline in neurodegenerative diseases

I Solés-Tarrés, N Cabezas-Llobet, D Vaudry… - Frontiers in cellular …, 2020 - frontiersin.org
Cognitive impairment is one of the major symptoms in most neurodegenerative disorders
such as Alzheimer's (AD), Parkinson (PD), and Huntington diseases (HD), affecting millions …

Local and long-range GABAergic circuits in hippocampal area CA1 and their link to Alzheimer's disease

M Hernández-Frausto, OM Bilash… - Frontiers in Neural …, 2023 - frontiersin.org
GABAergic inhibitory neurons are the principal source of inhibition in the brain. Traditionally,
their role in maintaining the balance of excitation-inhibition has been emphasized. Beyond …

[HTML][HTML] A more holistic perspective of Alzheimer's disease: roles of gut microbiome, adipocytes, HPA axis, melatonergic pathway and astrocyte mitochondria in the …

G Anderson - Frontiers in Bioscience-Landmark, 2023 - imrpress.com
Alzheimer's disease is widely regarded as poorly treated due to poor conceptualization. For
40 years, Alzheimer's disease pathophysiology has focused on two culprits, amyloid-β …

The Rho kinase inhibitor fasudil attenuates Aβ1–42-induced apoptosis via the ASK1/JNK signal pathway in primary cultures of hippocampal neurons

Y Gao, Y Yan, Q Fang, N Zhang, G Kumar… - Metabolic brain …, 2019 - Springer
Abstract Alzheimer's disease (AD), a chronic, progressive, neurodegenerative disorder, is
the most common type of dementia. Beta amyloid (Aβ) peptide aggregation and …

Early intervention attenuates synaptic plasticity impairment and neuroinflammation in 5xFAD mice

K Li, X Wang, Y Jiang, X Zhang, Z Liu, T Yin… - Journal of Psychiatric …, 2021 - Elsevier
Background As an increasing population of Alzheimer's disease (AD) patients year by year,
which is a serious threat to human health, an effective approach to prevent and treat AD is …

Sleep disturbance and Alzheimer's disease: the glial connection

A Sunkaria, S Bhardwaj - Neurochemical research, 2022 - Springer
Poor quality and quantity of sleep are very common in elderly people throughout the world.
Growing evidence has suggested that sleep disturbances could accelerate the process of …

[HTML][HTML] Current advancement of immunomodulatory drugs as potential pharmacotherapies for autoimmunity based neurological diseases

H Ashraf, P Solla, LA Sechi - Pharmaceuticals, 2022 - mdpi.com
Dramatic advancement has been made in recent decades to understand the basis of
autoimmunity-mediated neurological diseases. These diseases create a strong influence on …